Question 1

What are the potential benefits of participating in this trial compared to standard treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma clinical trial (NCT02947347). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from ibrutinib and rituximab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma clinical trial (NCT02947347). Contact the study team or your healthcare provider for specific answers.

Question 3

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma clinical trial (NCT02947347). Contact the study team or your healthcare provider for specific answers.

Question 4

What tests will be done to monitor my health during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma clinical trial (NCT02947347). Contact the study team or your healthcare provider for specific answers.

Question 5

How will this trial affect my current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma clinical trial (NCT02947347). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or complications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma clinical trial (NCT02947347). Contact the study team or your healthcare provider for specific answers.

What this study is about